Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.

Di Bella D, Erzegovesi S, Cavallini MC, Bellodi L.

Pharmacogenomics J. 2002;2(3):176-81.

2.

Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.

Bloch MH, Landeros-Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V, Pittenger C, Leckman JF.

Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):850-8. doi: 10.1002/ajmg.b.30699. Review.

PMID:
18186076
3.

Is serotonin transporter polymorphism (5-HTTLPR) allele status a predictor for obsessive-compulsive disorder? A meta-analysis.

Mak L, Streiner DL, Steiner M.

Arch Womens Ment Health. 2015 Jun;18(3):435-45. doi: 10.1007/s00737-015-0526-z. Epub 2015 Apr 21. Review.

PMID:
25896187
4.

Genetic aspects of obsessive-compulsive disorder.

Wolff M, Alsobrook JP 2nd, Pauls DL.

Psychiatr Clin North Am. 2000 Sep;23(3):535-44. Review.

PMID:
10986726
5.

Fluvoxamine as an antiobsessional agent.

Goodman WK, Price LH, Rasmussen SA, Heninger GR, Charney DS.

Psychopharmacol Bull. 1989;25(1):31-5. Review.

PMID:
2505302
6.

Pharmacogenetics of obsessive-compulsive disorders.

Brandl EJ, Müller DJ, Richter MA.

Pharmacogenomics. 2012 Jan;13(1):71-81. doi: 10.2217/pgs.11.133. Review.

PMID:
22176623
7.
8.

Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development.

Rosenberg DR, Hanna GL.

Biol Psychiatry. 2000 Dec 15;48(12):1210-22. Review.

PMID:
11137061
9.

Multiple rare SAPAP3 missense variants in trichotillomania and OCD.

Züchner S, Wendland JR, Ashley-Koch AE, Collins AL, Tran-Viet KN, Quinn K, Timpano KC, Cuccaro ML, Pericak-Vance MA, Steffens DC, Krishnan KR, Feng G, Murphy DL.

Mol Psychiatry. 2009 Jan;14(1):6-9. doi: 10.1038/mp.2008.83. Review. No abstract available.

Supplemental Content

Support Center